Your browser doesn't support javascript.
loading
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
Schmalbrock, Laura K; Dolnik, Anna; Cocciardi, Sibylle; Sträng, Eric; Theis, Frauke; Jahn, Nikolaus; Panina, Ekaterina; Blätte, Tamara J; Herzig, Julia; Skambraks, Sabrina; Rücker, Frank G; Gaidzik, Verena I; Paschka, Peter; Fiedler, Walter; Salih, Helmut R; Wulf, Gerald; Schroeder, Thomas; Lübbert, Michael; Schlenk, Richard F; Thol, Felicitas; Heuser, Michael; Larson, Richard A; Ganser, Arnold; Stunnenberg, Hendrik G; Minucci, Saverio; Stone, Richard M; Bloomfield, Clara D; Döhner, Hartmut; Döhner, Konstanze; Bullinger, Lars.
Affiliation
  • Schmalbrock LK; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Dolnik A; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Cocciardi S; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Germany.
  • Sträng E; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Theis F; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Jahn N; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Panina E; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Blätte TJ; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Herzig J; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Skambraks S; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Rücker FG; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Gaidzik VI; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Paschka P; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Fiedler W; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Salih HR; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Wulf G; Section of Pneumology, Department of Oncology, Hematology and Bone Marrow Transplantation, Hubertus Wald University Cancer Center, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Schroeder T; Department of Hematology and Oncology, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Lübbert M; Department of Hematology and Oncology, Georg-August-University Göttingen, Göttingen, Germany.
  • Schlenk RF; Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Thol F; Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Faculty of Medicine, Freiburg, Germany.
  • Heuser M; National Center of Tumor Diseases, NCT-Trial Center, German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.
  • Larson RA; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Stunnenberg HG; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Minucci S; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
  • Stone RM; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Bloomfield CD; Department of Molecular Biology, Faculty of Science, Radboud University, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • Döhner H; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.
  • Döhner K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
  • Bullinger L; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Blood ; 137(22): 3093-3104, 2021 06 03.
Article in En | MEDLINE | ID: mdl-33598693
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Staurosporine / Fms-Like Tyrosine Kinase 3 / Clonal Evolution / Mutation Type of study: Clinical_trials / Guideline Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2021 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Staurosporine / Fms-Like Tyrosine Kinase 3 / Clonal Evolution / Mutation Type of study: Clinical_trials / Guideline Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2021 Type: Article Affiliation country: Germany